Introduction
The 1,5-benzothiazepine is one of the three possible benzocondensed derivatives, viz. 1,4-, 4,1-and 1,5-benzothiazepines of the 1,4-thiazepine. 1 The parent 1,5-benzothiazepine has not yet been published in the chemical literature, but its derivatives are the most frequently investigated benzothiazepine type compounds. 2,3-Dihydro-1,5-benzothiazepin-4(5H)-ones are especially popular substances since they possess wide range of bioactivities. Therefore, the 1,5-benzothiazepines are useful compounds in the drug research which has stimulated the invention of a wide range of synthetic methods for their preparation and chemical transformations. This is due for the synthesis of optically active 1,5-benzothiazepines as well.
The major aim of this review is to provide examples for the synthesis of the known groups of the optically active 1,5-benzothiazepines. In some cases, the stereochemical studies of the synthesized new compounds are included. Their most important bioactivities will also be discussed together with the synthesis of special groups of substances.
Synthesis and Stereochemistry of Optically Active 2,3-Dihydro-1,5-benzothiazepin-4(5H)-ones Substituted at Position 2
The first representatives of the optically active 1,5-benzothiazepines were the enantiomers of the 2-(carboxymethyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one (3). Racemic 3 was prepared by the heating of a mixture of 2-aminothiophenol (1) and glutaconic acid (2) . Resolution of this racemate with brucine provided the (+)-3 and (-)-3 enantiomers 2 (Scheme 1). Since this work was published as early as 1927, absolute configuration data are not mentioned in this paper. This was the sole example for the preparation of optically active benzothiazepines for four decades. 3 A common feature of these two examples is that 1,5-benzothiazepines with a functional group capable of salt formation were synthesized as racemates. Optical resolution of these racemates provided the appropriate optically active 1,5-benzothiazepine enantiomers. For the synthesis of optically active 2,3-dihydro-1,5-benzothiazepin-4(5H)-ones substituted at position 2 a retrosynthetic approach was invented by Lévai et al. 4 This retrosynthetic approach enabled the first synthesis of optically active 2,3-dihydro-1,5-benzothiazepin-4(5H)-ones without functional groups capable of salt formation. Racemic nitrocarboxylic acids 4 and 5 5 were used as starting materials. Brucine salts of compounds 4 and 5 were crystallized from ethanol until each salt showed constant optical rotation, then the diastereomeric salts were decomposed with dilute hydrochloric acid to afford optically active nitrocarboxylic acid enantiomers. Optically active nitrocarboxylic acids were reduced to the appropriate aminocarboxylic acids 6 and 7 on treatment with Zn powder in acetic acid. Optically active 2,3-dihydro-1,5-benzothiazepin-4(5H)-ones 8 and 9 were obtained by the ring closure of the optically active aminocarboxylic acids 6 and 7 in boiling xylene 4 (Scheme 2).
Conformation of the seven-membered ring was determined by NMR spectroscopy. 6 Absolute configuration of the centre of chirality of these optically active 2,3-dihydro-1,5-benzothiazepin-4(5H)-ones (8, 9) and their optically active intermediates were elucidated by a combined utilization of X-ray diffraction analysis and circular dichroism (CD) spectroscopic measurements. 2,3-Dihydro-1,5-benzothiazepin-4(5H)-ones substituted at position 2 can also be prepared by the ring enlargements of 1-thiochromanones. 9 Either the Schmidt reaction of 1- 
Synthesis of Optically Active 3-Alkyl-2,3-dihydro-1,5-benzothiazepin-4(5H)-ones
The first representative of optically active 3-alkyl-2,3-dihydro-1,5-benzothiazepin-4(5H)-ones was synthesized by Ohno et al. 15 ,16 2-Aminothiophenol (1) was allowed to react with diethyl benzylidenemalonate (16) to obtain aminocarboxylic acid derivative 17 ring closure of which afforded 2,3-dihydro-3-(ethoxycarbonyl)-2-phenyl-1,5-benzothiazepin-4(5H)-one (18) . 
15,16
Compound 18 was then converted into 3-hydroxymethyl derivative 19 on reduction with LiAlH 4 . The hydroxy group was replaced by a chlorine atom and compound 20 was obtained which was reacted with N-methylpiperazine to yield a cis/trans mixture of 2,3-dihydro-3-[(4-methylpiperazinyl)methyl]-2-phenyl-1,5-benzothiazepin-4(5H)-one (21) (Scheme 5). The diastereomers were then separated and the cis-21 was optically resolved with tartaric acid to afford (-)-cis-2,3-dihydro-3-[(4-methylpiperazinyl)methyl]-2-phenyl-1,5-benzothiazepin-4(5H)-one as an optically pure substance. Its hydrochloride (BTM-1086) showed antiulcer and gastric secretary effects. 16, 17 It is worth mentioning that no data are available concerning the elucidation of the stereochemistry of 1,5-benzothiazepines 18-21.
Synthesis and Bioactivities of Optically Active 3-Amino-2,3-dihydro-1,5-benzothiazepin-4(5H)-ones
Optically active 3-amino-2,3-dihydro-1,5-benzothiazepin-4-(5H)-ones are especially useful substances in the drug research. One of their important effects is the angiotensin converting enzyme (ACE) inhibitory activity. The angiotensin converting enzyme (ACE) is a dipeptidyl carboxypeptidase catalyzing the hydrolysis of the decapeptide angiotensin I to the octapeptide angiotensin II. This octapeptide is a known vasoconstrictor promoting the release of the aldosterone. As a result, the ACE raises the blood pressure and, therefore, several ACE inhibitors are used to treat the hypertension and congestive heart failure. 18 For this reason, a wide variety of ACE inhibitors have been synthesized and tested. In this review, we discuss only the optically active 3-amino-2,3-dihydro-1,5-benzothiazepine type ACE inhibitors. The first representative of the optically active 3-amino-2,3-dihydro-1,5-benzothiazepin-4(5H)-ones was synthesized by Slade et al. 19 Source of the chirality was the L-cysteine as a natural amino acid used as building block. o-Fluoronitrobenzene ( Solid-phase synthesis of optically active 3-amino-2,3-dihydro-1,5-benzothiazepin-4(5H)-ones, using cysteine derivatives as building blocks, has also been described in the literature. 29 Amblard et al. [30] [31] [32] [33] Its effectiveness stimulated the efforts to develop various synthetic protocols for its preparation. These efforts were further supported by the fact that nowadays only optically pure active ingredients are allowed to use for the production and sale of medicines. Owing to the huge amount of literaterature data, in this paragraph we included only the most adequate selected examples to illustrate some procedures used for this purpose which means that not all papers published on this topic are included and discussed. The first synthesis of (+)-diltiazem was achieved by Inoue et al. 44 Utilization of optically active 3-phenylglycidates have been published by several research groups. [45] [46] [47] [48] Racemic nitrocarboxylic acid 49 or aminocarboxylic acid 50 intermediates were optically resolved via distereomeric salt formation. Optically active intermediates used for the synthesis of the diltiazem have also been prepared by enzyme-catalyzed resolution. [51] [52] [53] [54] In some cases, either the aminocarboxylic acid intermediates or the racemic 1,5-benzothiazepine derivatives were optically resolved to yield the optically active target compounds. 57 In special cases, optically active aminocarboxylic amides were used as intermediates for the preparation of (+)-diltiazem. Optical purity, conformation and absolute configuration of these optically active 1,5-benzothiazepines and their optically active intermediates have been elucidated by NMR spectroscopic measurements, X-ray diffraction analysis and circular dichroism (CD) spectroscopy. 49, [63] [64] [65] [66] Several metabolites of the diltiazem have been prepared and were found to possess various bioactivities. 43, [67] [68] [69] [70] [71] [72] [73] Biological and pharmacological activities of these benzothiazepines have been studied in numerous research laboratories and pharmaceutical companies. Their most important effects are antihypertensive, cardiovascular, spasmolytic, calcium channel blocking and antithrombotic activities. On all these bases, the 2,3-dihydro-3-hydroxy-1,5-benzothiazepin-4(5H)-oes are the most valuable benzothiazepine type compounds in the drug research.
Miscellaneous
In this closing paragraph, a few interesting representatives of the optically active 1,5-benzothiazepines are included. In special cases, optically active 1,5-benzothiazepines were synthesized by the reaction of optically active natural products or their semisynthetic derivatives with 2-aminothiophenol (1). Tronchet and Gentile 74 reacted the α,β-unsaturated ketone 65
derived from sugar with 2-aminothiophenol (1) to obtain a spirobenzothiazepine type compound 66 (Scheme 17). In the case of this optically active 1,5-benzothiazepine, the source of the chirality was the sugar used as building block. 74 Mushfiq et al. [75] [76] [77] synthesized optically active 1,5-benzothiazepines condensed with a steroid skeleton. Steroid derivatives 67 bearing an α,β-unsaturated ketone unit were allowed to react with 2-aminothiophenol (1) to afford the benzothiazepine derivatives 68 (Scheme 18). In these cases, the source of the chirality was the steroid building block.
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Conclusions
Chemistry of well known groups of optically active 1,5-benzothiazepines are summarized in this review article. The most important procedures used for their synthesis are discussed with the help of adequate examples. Their most valuable bioactivities are mentioned in brief. Selected original papers included in the References will help the reader to find the original information concerning a special 1,5-benzothiazepine derivative.
